Maricann Subsidiary, Mariplant, Commences Hemp Operations in Germany
TORONTO, April 18, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M)(OTCQB:MRRCF) (“Maricann” or the “Company”), is pleased to announce that the first seeds will be planted today on its contract farmed 164 hectares (~405 acre) of agricultural land in Saxony, Germany, through Mariplant GmbH a 95% owned subsidiary of the Company focused on nutraceutical non-THC cannabis. The cultivation site is less than 30 minutes drive from the Company’s Ebersbach Campus, near Dresden, Germany.
The Ebersbach facility is currently under retrofit of 8,000 sq. m (86,111 sq. ft) separated from its Maricann GmbH operations, to accommodate drying equipment capable of processing 1,000 kg of wet cannabis per hour. Storage and extraction equipment from Advanced Extraction Systems (AES) will be utilized to process up to 200 kg of cannabis flowers per day.1
Mariplant’s operation will focus on producing isolates of CBD and CBG, which are considered to be the most desirable cannabinoids. Maricann will add terpenoids and flavonoids in addition to its VesiSorb emulsion technology to create Mariplant products for distribution as food supplements across Germany and the greater European Union. Terpenoids and Flavonoids from Maricann’s Haxxon cultivation and extraction operation from feminized cannabis will be added to improve efficacy.
We believe that this large scale outdoor cannabis cultivation and extraction operation has the potential to reduce our costs of production significantly, specifically for isolate CBD, CBN and CBG. Through this initiative, we expect to be able to produce our own active ingredients for our products, reducing material costs of active ingredients for Mariplant products that we currently purchase from third parties.
Ben Ward, CEO of Maricann
Our expectation is that this will result in a further competitive advantage for Mariplant, benefiting in a differentiated product through VesiSorb’s patented delivery technology, with the end result of value creation for Maricann shareholders.
Mariplant is a standalone company in Germany registered for agriculture, with its General Manager Josef Spaeth who has the designation of registered farmer (Landwirt).
Mariplant will sell finished product VesiSorb gel capsules into the German market through its online shop www.mariplant.de.
About Maricann Group Inc.
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario, Canada where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada, and Dresden, Saxony, Germany. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, with a designed expected capacity of producing 95,000 kg (based on conservative estimates) of dry cannabis flower per year to support existing and future patient growth.
